Craft

Advanced
BioVex

BioVex

BioVex Summary

Company Summary

Overview
BioVex is a biotechnology company that develops potent biologics for the treatment of cancer and prevention of infectious disease. It is engaged in the development of OncoVEX(GM-CSF), an oncolytic vaccine that can be used to treat melanoma as well as head and neck cancer.
Type
Subsidiary
Status
Active
Founded
1999
Website
http://biovex.com
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Philip Astley-Sparke, President, Chief Executive Officer and Director

    • Stephen Gorgol, Chief Financial Officer , Treasurer and Secretary

      • Robert Coffin, Chief Technology Officer, Founder and Director

        • Colin Love, SVP Product Development

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX